描述
⋅ Valneva is developing a virus-disabled classical COVID vaccine with UK as its first client (Already 100M dosis preorder contract).
At each good news it pumps hard and then correct to the previous ATH before a new round.
By the way, be carefull as its vaccine will reach the phase I/II certification only in april. This will be a big milestone.